Literature DB >> 16793235

Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs.

J A Vizcarra1, J D Kirby, S K Kim, M L Galyean.   

Abstract

Ghrelin has been implicated in the control of food intake and in the long-term regulation of body weight. We theorize that preventing the ability of ghrelin to interact with its receptors, would eventually lead to decreased appetite and thereby decrease body weight gain. To test our hypothesis, pigs were actively immunized against ghrelin. Ghrelin((1-10)) was conjugated to BSA and emulsified in Freund's incomplete adjuvant and diethylaminoethyl-dextran. Primary immunization was given at 19 weeks of age (WOA), with booster immunizations given 20 and 40 days after primary immunization. Body weight (BW) and plasma samples were collected weekly beginning at 19 WOA, and feed intake was measured daily. Fourteen days after primary immunization, the percentage of bound (125)I-ghrelin in plasma from immunized pigs was increased compared with control animals (P<0.001). Voluntary feed intake was decreased more than 15% in animals that were actively immunized against ghrelin compared with controls. By the end of the experiment, immunized pigs weighed 10% less than control animals (P<0.1). Concentrations of GH were increased (P<0.05) in immunized pigs. Apoptosis was not observed in post-mortem samples obtained from the fundic region of the stomach. Our observations suggest that immunization against ghrelin induces mild anorexia. This procedure could potentially be used as a treatment to control caloric intake and obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793235     DOI: 10.1016/j.domaniend.2006.05.005

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  15 in total

1.  Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice.

Authors:  Joseph S Zakhari; Eric P Zorrilla; Bin Zhou; Alexander V Mayorov; Kim D Janda
Journal:  Mol Pharm       Date:  2011-12-23       Impact factor: 4.939

Review 2.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

4.  Nanogel-based nasal ghrelin vaccine prevents obesity.

Authors:  T Azegami; Y Yuki; S Sawada; M Mejima; K Ishige; K Akiyoshi; H Itoh; H Kiyono
Journal:  Mucosal Immunol       Date:  2017-01-25       Impact factor: 7.313

5.  Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study.

Authors:  Aldar S Bourinbaiar; Vichai Jirathitikal
Journal:  Lipids Health Dis       Date:  2010-02-02       Impact factor: 3.876

6.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

Review 7.  Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

Review 8.  Obesity vaccines.

Authors:  Mariana P Monteiro
Journal:  Hum Vaccin Immunother       Date:  2013-12-23       Impact factor: 3.452

Review 9.  Pharmacological Modulation of Ghrelin to Induce Weight Loss: Successes and Challenges.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  Curr Diab Rep       Date:  2019-09-10       Impact factor: 4.810

Review 10.  Current and future drug targets in weight management.

Authors:  Renger F Witkamp
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.